Human acute myeloid leukemia cells (AML, U937 cells) exposed to plasma EVs from patients with newly diagnosed and recurrent AML exhibited an increase in idarubicin resistance concomitant with upregulation of P-gp and MRP1 mRNA expression. The gene discussed is PGP; the disease is acute myeloid leukemia.